These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33409784)

  • 41. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas.
    Lasocki A; Gaillard F; Gorelik A; Gonzales M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):687-692. PubMed ID: 29519793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of T2W hypointense ring as a novel noninvasive indicator for glioma grade and IDH genotype.
    Lu Y; Du N; Fang X; Shu W; Liu W; Xu X; Ye Y; Xiao L; Mao R; Li K; Lin G; Li S
    Cancer Imaging; 2024 Jun; 24(1):80. PubMed ID: 38943156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
    Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
    Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
    Kanazawa T; Minami Y; Takahashi H; Fujiwara H; Toda M; Jinzaki M; Yoshida K; Sasaki H
    Neurosurg Rev; 2020 Aug; 43(4):1211-1219. PubMed ID: 31402410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
    Kihira S; Derakhshani A; Leung M; Mahmoudi K; Bauer A; Zhang H; Polson J; Arnold C; Tsankova NM; Hormigo A; Salehi B; Pham N; Ellingson BM; Cloughesy TF; Nael K
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas.
    Pei D; Guan F; Hong X; Liu Z; Wang W; Qiu Y; Duan W; Wang M; Sun C; Wang W; Wang X; Guo Y; Wang Z; Liu Z; Xing A; Guo Z; Luo L; Liu X; Cheng J; Zhang B; Zhang Z; Yan J
    Eur Radiol; 2023 May; 33(5):3455-3466. PubMed ID: 36853347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T2-FLAIR mismatch sign correlates with
    Ebiko Y; Tamura K; Hara S; Inaji M; Tanaka Y; Nariai T; Ishii K; Maehara T
    J Neurooncol; 2023 Aug; 164(1):257-265. PubMed ID: 37589920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T2-FLAIR Mismatch: An Imaging Biomarker for Children's
    van Maren EA; Dankbaar JW; Wesseling P; Plasschaert S; Muhlebner A; Hoving EW; Robe PA; Snijders TJ; Hoogendijk R; Kranendonk MEG; Lequin MH
    AJNR Am J Neuroradiol; 2024 Jun; 45(6):747-752. PubMed ID: 38724203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma.
    Sawlani V; Jen JP; Patel M; Jain M; Haq H; Ughratdar I; Wykes V; Nagaraju S; Watts C; Pohl U
    Clin Radiol; 2024 Mar; 79(3):197-204. PubMed ID: 38101998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor.
    Onishi S; Amatya VJ; Kolakshyapati M; Takano M; Yonezawa U; Taguchi A; Kaichi Y; Takeshima Y; Awai K; Sugiyama K; Kurisu K; Yamasaki F
    Eur J Radiol; 2020 May; 126():108924. PubMed ID: 32193035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomas.
    Lasocki A; Buckland ME; Drummond KJ; Wei H; Xie J; Christie M; Neal A; Gaillard F
    Neuroradiology; 2022 Dec; 64(12):2295-2305. PubMed ID: 35606654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
    Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.
    Ozono I; Onishi S; Yonezawa U; Taguchi A; Khairunnisa NI; Amatya VJ; Yamasaki F; Takeshima Y; Horie N
    J Neurooncol; 2024 Sep; 169(3):571-579. PubMed ID: 38995493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T2-FLAIR mismatch sign: a roadmap of pearls and pitfalls.
    Pinto C; Noronha C; Taipa R; Ramos C
    Br J Radiol; 2022 Jan; 95(1129):20210825. PubMed ID: 34618597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma.
    Nadeem M; Shahzad UB; Tahir N; Areej A
    Neurosurg Rev; 2024 Aug; 47(1):512. PubMed ID: 39212803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas.
    Johnson DR; Kaufmann TJ; Patel SH; Chi AS; Snuderl M; Jain R
    Neuroradiology; 2019 Feb; 61(2):225-227. PubMed ID: 30565056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.
    Malik P; Soliman R; Chen YA; Munoz DG; Das S; Bharatha A; Mathur S
    Neuroradiology; 2024 Apr; 66(4):521-530. PubMed ID: 38347151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of the T2-FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas.
    Kapsalaki EZ; Brotis AG; Tsikrika A; Tzerefos C; Paschalis T; Dardiotis E; Fountas KN
    Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33228171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.
    Zang Y; Feng L; Zheng F; Shi X; Chen X
    Clin Neurol Neurosurg; 2024 Nov; 246():108579. PubMed ID: 39395280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T2-Fluid-Attenuated Inversion Recovery (FLAIR) Mismatch as a Novel Specific MRI Marker for Adult Low-Grade Glioma (LGG): A Case Report.
    Slaghour RM; Almarshedi RA; Alzahrani AM; Albadr F
    Cureus; 2022 Sep; 14(9):e29457. PubMed ID: 36299937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.